NASDAQ · EQUITY · ENHANCED MARKET DYNAMICS

RLYB

Rallybio Corp

US · Healthcare · Biotechnology

Open Chart Terminal

EMD SCORE76/100

CURRENT COMPLETED-WEEK READ

Strongly constructive

The latest completed-week readings are broadly supportive. Conditions remain positive, but momentum has eased.

Constructive fade100% directional agreement100/100 evidence quality6/6 sources available

Completed week: 9 Oct 2026
Latest close: USD 17.02
Evidence: 156 weeks

Four-week EMD change-0.4 pts

signed chart scale −100 to +100

Four-week price+0.9%

completed closing prices

Current directional run63 weeks

on the same side of EMD zero

Recent consistency13/13

recent readings above zero

COMPLETED-WEEK OVERVIEW

Price and market conditions over time

4 supportive · 0 cautious

Enhanced Market Dynamics and the price cycle156 completed weeks · bars use the left EMD axis; price uses the right axis.

20 Oct 2023–9 Oct 2026

Constructive EMDCautious EMDCompleted-week priceUp-cycle confirmationDown-cycle confirmation

Confirmation markers describe price-zone departures within this saved history. Earlier markers can change as the history changes; they are not a record of signals available in real time.

Cycle position 93%Current EMD +52.94-week EMD change -0.4Full saved history price range USD 2.00–33.12

View chart values · 156 observations

Week	Close · USD	EMD −100 to +100	Score /100	Agreement %	Coverage %
2023-10-20	27.04	-51.87	24	60	83
2023-10-27	32.16	-40.57	30	50	83
2023-11-03	33.12	-43.8	28	50	83
2023-11-10	22.96	-47.71	26	60	100
2023-11-17	15.92	-60.78	20	67	100
2023-11-24	19.52	-37.63	31	33	100
2023-12-01	17.84	-38.67	31	33	100
2023-12-08	23.12	-24.27	38	20	100
2023-12-15	24.32	-23.02	38	20	100
2023-12-22	21.12	-30.79	35	33	100
2023-12-29	19.12	-29.36	35	33	100
2024-01-05	16.96	-45.4	27	67	100
2024-01-12	15.28	-44.83	28	67	100
2024-01-19	11.52	-50.57	25	67	100
2024-01-26	11.12	-49.7	25	67	100
2024-02-02	10.48	-53.43	23	67	100
2024-02-09	14.16	-29.27	35	33	100
2024-02-16	16.00	-17.07	41	0	100
2024-02-23	13.60	-34.44	33	60	100
2024-03-01	18.88	-13.74	43	20	100
2024-03-08	14.96	-32.17	34	60	100
2024-03-15	12.96	-46.07	27	100	100
2024-03-22	12.80	-41.47	29	100	100
2024-03-29	14.80	-36.29	32	60	100
2024-04-05	13.04	-46.9	27	100	100
2024-04-12	17.60	-22.36	39	50	100
2024-04-19	14.08	-20.8	40	20	100
2024-04-26	13.60	-22.91	39	33	100
2024-05-03	14.64	-11.97	44	0	100
2024-05-10	14.64	-32.3	34	60	100
2024-05-17	14.16	-30.17	35	50	100
2024-05-24	12.48	-37.3	31	60	100
2024-05-31	13.36	-23.74	38	20	100
2024-06-07	11.84	-42.68	29	100	100
2024-06-14	12.36	-37.36	31	100	100
2024-06-21	11.68	-37.14	31	100	100
2024-06-28	10.72	-52.71	24	60	100
2024-07-05	10.64	-32.39	34	33	100
2024-07-12	11.04	-45.37	27	100	100
2024-07-19	10.72	-48.67	26	100	100
2024-07-26	10.88	-41.58	29	100	100
2024-08-02	10.08	-51.22	24	100	100
2024-08-09	9.12	-53.25	23	100	100
2024-08-16	8.80	-55.92	22	100	100
2024-08-23	9.04	-53.72	23	100	100
2024-08-30	9.20	-53.75	23	100	100
2024-09-06	8.80	-52.16	24	100	100
2024-09-13	9.04	-44.36	28	100	100
2024-09-20	8.80	-51.97	24	100	100
2024-09-27	8.84	-47.26	26	100	100
2024-10-04	8.88	-42.82	29	100	100
2024-10-11	8.80	-42.94	29	100	100
2024-10-18	8.96	-17.35	41	50	100
2024-10-25	8.24	-33.19	33	33	100
2024-11-01	8.08	-33.49	33	50	100
2024-11-08	8.00	-35.41	32	60	100
2024-11-15	7.93	-36.4	32	60	100
2024-11-22	8.16	-28.55	36	50	100
2024-11-29	9.36	-11.28	44	20	100
2024-12-06	8.48	-19.46	40	0	100
2024-12-13	8.64	-23.5	38	0	100
2024-12-20	7.60	-31.94	34	33	100
2024-12-27	7.31	-27.45	36	20	100
2025-01-03	8.08	-19.9	40	20	100
2025-01-10	7.52	-34.96	33	60	100
2025-01-17	7.00	-36.13	32	60	100
2025-01-24	7.04	-36.51	32	100	100
2025-01-31	6.88	-43.39	28	100	100
2025-02-07	6.75	-42.19	29	67	100
2025-02-14	6.03	-46.89	27	67	100
2025-02-21	6.03	-46.69	27	67	100
2025-02-28	5.78	-51.56	24	100	100
2025-03-07	5.95	-43.03	28	60	100
2025-03-14	5.06	-58.74	21	100	100
2025-03-21	5.36	-56.28	22	100	100
2025-03-28	5.12	-51.25	24	67	100
2025-04-04	3.60	-57.39	21	67	100
2025-04-11	2.00	-60.79	20	67	100
2025-04-18	2.00	-48.99	26	60	100
2025-04-25	2.43	-39.53	30	33	100
2025-05-02	2.54	-54.85	23	100	100
2025-05-09	2.34	-52.41	24	100	100
2025-05-16	2.80	-35.6	32	50	100
2025-05-23	2.63	-48.19	26	100	100
2025-05-30	2.47	-54.99	23	100	100
2025-06-06	3.16	-31.45	34	50	100
2025-06-13	2.59	-60.25	20	100	100
2025-06-20	2.45	-55.13	22	100	100
2025-06-27	2.66	-36.99	32	100	100
2025-07-04	2.66	-42.22	29	100	100
2025-07-11	3.25	-22.96	39	50	100
2025-07-18	3.44	-15.66	42	20	100
2025-07-25	3.99	-5.27	47	33	100
2025-08-01	4.28	8.64	54	33	100
2025-08-08	4.25	8.07	54	50	100
2025-08-15	4.83	22.93	61	67	100
2025-08-22	5.01	21.01	61	67	100
2025-08-29	4.29	8.79	54	33	100
2025-09-05	4.87	26.9	63	67	100
2025-09-12	4.81	15.36	58	60	100
2025-09-19	4.71	22.75	61	60	100
2025-09-26	4.40	23.36	62	33	100
2025-10-03	4.52	26.44	63	67	100
2025-10-10	4.09	15.02	58	33	100
2025-10-17	4.28	19.36	60	60	100
2025-10-24	4.88	30.54	65	67	100
2025-10-31	5.58	42.43	71	67	100
2025-11-07	5.00	27.08	64	33	100
2025-11-14	5.12	28.57	64	33	100
2025-11-21	5.02	31.37	66	60	100
2025-11-28	5.21	31.2	66	60	100
2025-12-05	5.29	37.24	69	60	100
2025-12-12	5.86	64.98	82	100	100
2025-12-19	6.28	75.41	88	100	100
2025-12-26	5.50	51.88	76	67	100
2026-01-02	5.66	69.7	85	100	100
2026-01-09	5.68	63.22	82	100	100
2026-01-16	5.25	41.5	71	67	100
2026-01-23	5.37	54.76	77	100	100
2026-01-30	5.14	32.81	66	100	100
2026-02-06	4.75	6.94	53	50	100
2026-02-13	4.82	11.29	56	50	100
2026-02-20	5.06	10.0	55	0	100
2026-02-27	7.54	57.61	79	67	100
2026-03-06	10.91	75.5	88	100	100
2026-03-13	9.50	62.08	81	67	100
2026-03-20	8.87	61.82	81	67	100
2026-03-27	8.22	64.65	82	67	100
2026-04-03	8.43	62.64	81	100	100
2026-04-10	8.44	67.39	84	100	100
2026-04-17	8.22	62.99	81	100	100
2026-04-24	8.63	69.51	85	100	100
2026-05-01	9.41	78.52	89	100	100
2026-05-08	14.38	76.68	88	100	100
2026-05-15	14.30	80.25	90	100	100
2026-05-22	15.88	81.44	91	100	100
2026-05-29	14.46	76.75	88	100	100
2026-06-05	15.95	60.93	80	67	100
2026-06-12	15.92	75.05	88	100	100
2026-06-19	15.97	70.11	85	100	100
2026-06-26	16.00	75.71	88	100	100
2026-07-03	15.82	70.08	85	100	100
2026-07-10	15.73	69.92	85	100	100
2026-07-17	16.42	79.83	90	100	100
2026-07-24	16.31	70.28	85	100	100
2026-07-31	15.93	61.28	81	67	100
2026-08-07	16.16	64.61	82	100	100
2026-08-14	16.99	66.1	83	100	100
2026-08-21	16.83	57.2	79	100	100
2026-08-28	16.81	58.82	79	100	100
2026-09-04	16.92	56.62	78	100	100
2026-09-11	16.88	53.36	77	100	100
2026-09-18	17.19	59.99	80	100	100
2026-09-25	16.62	43.5	72	60	100
2026-10-02	17.08	55.32	78	100	100
2026-10-09	17.02	52.92	76	100	100

SIX SOURCES · LAST 26 OBSERVATIONS

Is support broadening or thinning?

Green is supportive, rose is cautious.
Grey means the reading is unavailable.

Reading	17 Apr	24 Apr	1 May	8 May	15 May	22 May	29 May	5 Jun	12 Jun	19 Jun	26 Jun	3 Jul	10 Jul	17 Jul	24 Jul	31 Jul	7 Aug	14 Aug	21 Aug	28 Aug	4 Sep	11 Sep	18 Sep	25 Sep	2 Oct	9 Oct
Trend	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	99	100	99
Momentum	70	89	96	99	99	99	99	95	96	83	95	80	80	86	85	83	78	82	74	84	76	67	73	65	71	72
Underlying pressure	80	77	78	86	90	93	95	94	93	93	93	93	93	92	90	86	79	69	59	53	52	51	52	50	47	46
Price & volume	50	52	72	55	61	62	46	22	46	45	48	46	47	70	45	44	47	57	48	49	51	51	64	42	58	51
Relative strength	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100
Modeled Trend	89	90	90	90	90	90	90	90	90	90	91	91	90	90	90	90	90	90	90	90	90	90	90	90	90	90

Each cell is a finished component score from 0–100. Components can disagree even when the combined reading stays positive.

STRONGEST CURRENT SOURCE

Relative strength

100/100

LEAST SUPPORTIVE SOURCE

Underlying pressure

46/100

WHAT WOULD CHANGE THE READ?

Three paths to keep in view

Conditional research scenarios.
No assumed price target or timing.

Continuation

Price and evidence stay together

Look for the current direction to hold across trend, pressure and relative strength. A rising price with weaker EMD is a less convincing continuation.

Change of direction

Watch for loss of support

If price keeps rising while EMD falls, inspect which readings are weakening. Broad deterioration matters more than a single soft week.

Cycle context

A range extreme is a location

An upper zone can persist during a strong advance; a lower zone can persist during a decline. Use departures, EMD direction and the related price charts together.

EARLIER COMPARABLE READINGS

What followed similar conditions?

Same ticker · similar score and direction of change.
Returns exclude costs and dividends.

4 WEEKS LATER+2.7%

Median price return · 7 non-overlapping examples

Observed range: -16.4% to +11.6%
Positive returns: 71%
All-period comparison: -2.3% median

13 WEEKS LATER+44.8%

Median price return · 3 non-overlapping examples

Observed range: +8.2% to +87.6%
Positive returns: 100%
All-period comparison: -5.9% median

How these comparisons are selected

Earlier observations must have the same constructive/fading/repair/deterioration condition, a score within ten points of today’s score and at least the same component coverage. The first 30 observations are omitted for warm-up; examples are spaced by the forward horizon to avoid overlap. Gapped return windows are excluded. The all-period comparison uses the same available history and spacing, without matching the current state. These are reconstructed observations, not a point-in-time strategy backtest or a forecast.

RECENT CYCLE HISTORY

How the current reading developed

15 May 2026Upper cycle zone confirmedUSD 14.30

24 Oct 2025Up-cycle confirmedUSD 4.88

22 Aug 2025Up-cycle confirmedUSD 5.01

29 Nov 2024Up-cycle confirmedUSD 9.36

14 Jun 2024Lower cycle zone confirmedUSD 12.36

THE FULL PRICE CYCLE

Follow the journey from one zone to the other

Cycle states use trailing completed-week observations.

Lower zone

Price establishes residence near the bottom of its long-cycle range. Improving EMD separates early repair from continued deterioration.

Upward journey

Price leaves the lower zone while EMD confirms improving participation. The objective is the broader move toward the upper zone, not a short weekly trade.

Upper zone

Price establishes residence near the top of its long-cycle range. A high range position can persist. Watch EMD for exhaustion and loss of support before interpreting it as a turn.

Downward journey

Price leaves the upper zone while EMD weakens. The reverse cycle remains active until lower-zone residence is confirmed again.

CURRENT READINGS